This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jung, R.
Right arrow Articles by Fish, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jung, R.
Right arrow Articles by Fish, D. N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2004, p. 1055-1057, Vol. 48, No. 3
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.3.1055-1057.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Synergistic Activities of Moxifloxacin Combined with Piperacillin-Tazobactam or Cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii Clinical Isolates

Rose Jung,* Maroof Husain, Michael K. Choi, and Douglas N. Fish

Antimicrobial Research Laboratory, Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262

Received 14 April 2003/ Returned for modification 4 October 2003/ Accepted 5 December 2003

The bactericidal activity of moxifloxacin alone and in combination with cefepime or piperacillin-tazobactam against clinical isolates of Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii was evaluated by using time-kill methods and antimicrobial concentrations of one-half and one times the MIC. Synergy was observed in 58 to 88% of the strains and resulted in bactericidal activity against 60 to 100% of the strains. Combinations including moxifloxacin demonstrated enhanced bactericidal activity compared with that of either agent tested alone.

* Corresponding author. Mailing address: University of Colorado Health Sciences Center, Department of Clinical Pharmacy, School of Pharmacy, 4200 East Ninth Ave., Campus Box C-238, Denver, CO 80262. Phone: (303) 315-2664. Fax: (303) 315-4630. E-mail: rose.jung{at}uchsc.edu.

Antimicrobial Agents and Chemotherapy, March 2004, p. 1055-1057, Vol. 48, No. 3
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.3.1055-1057.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Liu, I-F., Annamalai, T., Sutherland, J. H., Tse-Dinh, Y.-C. (2009). Hydroxyl Radicals Are Involved in Cell Killing by the Bacterial Topoisomerase I Cleavage Complex. J. Bacteriol. 191: 5315-5319 [Abstract] [Full Text]  
  • Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
  • Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 3471-3484 [Full Text]  
  • Li, R. C., Tang, M. C. (2004). Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure. J Antimicrob Chemother 54: 904-908 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»